Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients

Arthritis and Rheumatism

Volumn 56, Issue 4, 2007, Pages 1087-1093

  Huber, Lars C ^a   Brock, Matthias ^a   Hemmatazad, Hossein ^a   Giger, Olivier T ^a   Moritz, Falk ^a   Trenkmann, Michelle ^a   Distler, Jörg H W ^a   Gay, Renate E ^a   Kolling, Christoph ^b   Moch, Holger ^a   Michel, Beat A ^a   Gay, Steffen ^a   Distler, Oliver ^a   Jüngel, Astrid ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b SCHULTHESS CLINIC   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2;

ACETYLATION; ADULT; AGED; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JOINT PROSTHESIS; MALE; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; SYNOVIUM; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; CELL NUCLEUS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; OSTEOARTHRITIS; REPRESSOR PROTEINS; SYNOVIAL MEMBRANE;

EID: 34247227700     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22512     Document Type: Article

References (25)

1. Urnov FD, Wolffe AP. Chromatin remodeling and transcriptional activation: the cast (in order of appearance). Oncogene 2001;20:2991-3006.
2. Ito K, Adcock IM. Histone acetylation and histone deacetylation. Mol Biotechnol 2002;20:99-106.
3. Ito K, Hanazawa T, Tomita K, Barnes PJ, Adcock IM. Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. Biochem Biophys Res Commun 2004;315:240-5.
4. Marwick JA, Kirkham PA, Stevenson CS, Danahay H, Giddings J, Butler K, et al. Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. Am J Respir Cell Mol Biol 2004;31:633-42.
5. Beato M. Chromatin structure and the regulation of gene expression: remodeling at the MMTV promoter. J Mol Med 1996;74:711-24.
6. Beato M, Eisfeld K. Transcription factor access to chromatin. Nucleic Acids Res 1997;25:3559-63.
7. Perry M, Chalkley R. Histone acetylation increases the solubility of chromatin and occurs sequentially over most of the chromatin: a novel model for the biological role of histone acetylation. J Biol Chem 1982;257:7336-47.
8. Ura K, Kurumizaka H, Dimitrov S, Almouzni G, Wolffe AP. Histone acetylation: influence on transcription, nucleosome mobility and positioning, and linker histone-dependent transcriptional repression. EMBO J 1997;16:2096-107.
9. Wolffe AP. Transcriptional control: sinful repression. Nature 1997;387:16-7.
10. De Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003;370(Pt 3):737-49.
11. Barnes PJ, Adcock IM, Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 2005;25:552-63.
12. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005;352:1967-76.
13. Chen LF, Greene WC. Assessing acetylation of NF-κB. Methods 2005;36:368-75.
14. Adcock IM, Cosio B, Tsaprouni L, Barnes PJ, Ito K. Redox regulation of histone deacetylases and glucocorticoid-mediated inhibition of the inflammatory response. Antioxid Redox Signal 2005;7:144-52.
15. Granet C, Maslinski W, Miossec P. Increased AP-1 and NF-κB activation and recruitment with the combination of the proinflammatory cytokines IL-1β, tumor necrosis factor α and IL-17 in rheumatoid synoviocytes. Arthritis Res Ther 2004;6:R190-8.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
17. Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, et al. A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci U S A 2002;99:8921-6.
18. Huang BH, Laban M, Leung CH, Lee L, Lee CK, Salto-Tellez M, et al. Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1. Cell Death Differ 2005;12:395-404.
19. Barnes PJ. How corticosteroids control inflammation: Quintiles Prize Lecture 2005. Br J Pharmacol 2006;148:245-54.
20. Chung YL, Lee MY, Wang AJ, Yao LF. A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. Mol Ther 2003;8:707-17.
21. Blanchard F, Chipoy C. Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases? Drug Discov Today 2005;10:197-204.
22. Ashburner BP, Westerheide SD, Baldwin AS Jr. The p65 (RelA) subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 2001;21:7065-77.
23. Ito K, Yamamura S, Essilfie-Quaye S, Cosio B, Ito M, Barnes PJ, et al. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression. J Exp Med 2005. E-pub ahead of print.
24. Place RF, Noonan EJ, Giardina C. HDAC inhibition prevents NF-κ B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I κ B α. Biochem Pharmacol 2005;70:394-406.
25. Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T. Synovial fibroblasts: key players in rheumatoid arthritis [review]. Rheumatology (Oxford) 2006;45:669-75.